| Patient | Gilda Radner |
|---|---|
| Date of birth | 1986-06-28 |
| Identifiers | MRN HR-ML026-SYN; SSN (made up) 000-26-8821 |
| Document date | 2026-06-09 |
| Author | Delia Marchand, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Sore throat, runny nose and cough for two days, a week after chemotherapy. [S]
Ms. Radner called the clinic on day 8 of her second cycle of carboplatin and paclitaxel and was seen the same day. For two days she has had a scratchy sore throat, a runny nose and a dry cough, after a friend she works with had a cold. She checked her temperature twice a day as she was taught: the highest was 37.6 °C, never 38.0 °C. She has no shortness of breath, chest pain, burning on passing urine, diarrhea, or redness at the incision. She ate and drank normally yesterday; the nausea after cycle 2 lasted two days and settled with ondansetron. The surgical wound is healed. Her mood is steady, and she has had no thoughts of self-harm. [S]
| Element | Detail |
|---|---|
| Onset | Two days ago, after contact with a friend who had a cold |
| Symptoms | Sore throat, runny nose, dry cough |
| Temperature | Highest 37.6 °C at home; 37.5 °C today; never 38.0 °C |
| Context | Day 8 of cycle 2 of carboplatin and paclitaxel, when the white count is expected to be near its lowest |
| Modifying factors | Warm drinks and throat lozenges help |
| Associated signs and symptoms | No breathlessness, chest pain, urinary symptoms, diarrhea, wound redness, or thoughts of self-harm |
| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | No fever of 38.0 °C or more, chills, or rigors |
| Ears, nose, mouth, and throat | Positive | Sore throat and runny nose; no ear pain or mouth sores |
| Respiratory | Positive | Dry cough; no shortness of breath or chest pain |
| Gastrointestinal | Negative | No vomiting or diarrhea; nausea settled |
| Genitourinary | Negative | No burning or frequency |
| Integumentary | Negative | Wound healed; no redness |
6 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Enoxaparin 40 mg/0.4 mL prefilled syringe, 40 mg under the skin once daily for 28 days after surgery | 40 mg under the skin once daily for 28 days | Subcutaneous route | 2026-04-21 to 2026-05-18 | completed | S |
| Acetaminophen 500 mg oral tablet, two tablets by mouth every 6 hours as needed for pain after surgery, no more than 3 g a day | Two tablets every 6 hours as needed | Oral route | 2026-04-21 to 2026-05-05 | completed | S |
| Carboplatin 10 mg/mL injection, 610 mg (AUC 5) intravenously on day 1 of each 21-day cycle, for six cycles | Day 1 every 21 days for six cycles | Intravenous route | 2026-05-12 to 2026-08-25 | completed | S |
| Paclitaxel 6 mg/mL injection, 275 mg (175 mg/m2) intravenously over 3 hours on day 1 of each 21-day cycle, for six cycles, after dexamethasone, diphenhydramine and famotidine | Day 1 every 21 days for six cycles | Intravenous route | 2026-05-12 to 2026-08-25 | completed | S |
| Ondansetron 8 mg oral tablet, one tablet by mouth every 8 hours as needed for nausea | One tablet every 8 hours as needed for nausea | Oral route | 2026-05-12 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-06-09 | Body height | 160 | cm | S |
| 2026-06-09 | Body weight | 55.8 | kg | S |
| 2026-06-09 | Body mass index (BMI) [Ratio] | 21.8 | kg/m2 | S |
| 2026-06-09 | Systolic blood pressure | 108 | mm[Hg] | S |
| 2026-06-09 | Diastolic blood pressure | 68 | mm[Hg] | S |
| 2026-06-09 | Heart rate | 88 | /min | S |
| 2026-06-09 | Respiratory rate | 16 | /min | S |
| 2026-06-09 | Body temperature | 37.5 | Cel | S |
| 2026-06-09 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-06-09 | Hemoglobin [Mass/volume] in Blood | 10.6 | g/dL | 11.6-15 g/dL | Low | S |
| 2026-06-09 | Leukocytes [#/volume] in Blood by Automated count | 2.9 | 10*3/uL | 4-11 10*3/uL | Low | S |
| 2026-06-09 | Neutrophils [#/volume] in Blood by Automated count | 1.3 | 10*3/uL | 1.5-7.7 10*3/uL | Low | S |
| 2026-06-09 | Platelets [#/volume] in Blood by Automated count | 142 | 10*3/uL | 150-400 10*3/uL | Low | S |
Vital signs recorded on 2026-06-09; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Well and comfortable; temperature 37.5 °C, pulse 88, blood pressure 108/68, respiratory rate 16, oxygen saturation 98% on room air |
| Head, eyes, ears, nose, and throat | Mildly red throat without exudate; clear nasal discharge; ear drums normal; no mouth ulcers |
| Neck | No tender or enlarged nodes |
| Respiratory | Clear to auscultation bilaterally; no crackles |
| Abdomen | Midline incision healed; soft and non-tender |
| Skin | No rash; peripheral line sites clean |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Persistent bloating with tightness of her clothes, feeling full after a few bites, a dull lower abdominal and pelvic ache, and passing urine more often, on most days for about four weeks, in a woman of 39: the ovarian cancer symptom index is positive. Examination: a distended abdomen with shifting dullness and a firm, fixed, irregular mass in the right adnexa. Suspected ovarian cancer; transvaginal ultrasound, CT, CA-125 and gynecologic oncology review booked within the week | resolved | confirmed | R19.00 | S — Synthetic presenting problem linked to her documented abdominal symptoms; superseded by the diagnosis at the gynecologic oncology consultation. |
| High-grade serous carcinoma of both ovaries (Mullerian origin), diagnosed by image-guided omental core biopsy (PAX8 and WT1 positive, p53 aberrant), with bilateral adnexal masses, ascites, omental and diaphragmatic disease on CT: clinical FIGO stage IIIC; synthetic modern detail linked to her documented ovarian cancer | active | confirmed | C56.3 | S — Synthetic histology and stage; the documented diagnosis was stage IV ovarian cancer (D). |
| Peritoneal and omental metastases of the ovarian cancer, with ascites | active | confirmed | C78.6 | S — Synthetic extent of disease on CT and biopsy. |
| Family history of ovarian cancer in three relatives (her grandmother, an aunt, and a cousin) in a woman of Ashkenazi Jewish ancestry; no genetic testing in the family is known | active | confirmed | Z80.41 | S — Synthetic coding of her documented family history; the basis for genetic counseling. |
| Acute viral upper respiratory infection on day 8 of the second chemotherapy cycle: two days of sore throat, runny nose and a dry cough, without fever; rapid influenza and COVID-19 tests negative; resolved | active | confirmed | J06.9 | S — Synthetic acute infection; not a historical claim. |
| Symptomatic surgical menopause after bilateral salpingo-oophorectomy at 39: hot flashes and night sweats | active | confirmed | E89.41 | S — Synthetic consequence of the synthetic operation. |
Guideline basis: NCCN Clinical Practice Guidelines in Oncology: Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer, Version 4.2026 (2026); NCCN Clinical Practice Guidelines in Oncology: Prevention and Treatment of Cancer-Related Infections (2026)
Follow-up: Phone check in two days. Call at once for a temperature of 38.0 °C or more. Cycle 3 as booked. Next scheduled visit 2026-07-14: midpoint of chemotherapy: CA-125, blood counts, neuropathy, and menopausal symptoms. [S]